{"created":"2023-05-15T13:16:23.953307+00:00","id":1089,"links":{},"metadata":{"_buckets":{"deposit":"6f29130a-6c64-42c9-bfea-b5f72945089c"},"_deposit":{"created_by":13,"id":"1089","owners":[13],"pid":{"revision_id":0,"type":"depid","value":"1089"},"status":"published"},"_oai":{"id":"oai:ncu.repo.nii.ac.jp:00001089","sets":["105:106:221:302"]},"author_link":["1748"],"item_10006_date_granted_11":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2015-03-25"}]},"item_10006_degree_grantor_9":{"attribute_name":"学位授与機関","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_name":"名古屋市立大学"}]}]},"item_10006_dissertation_number_12":{"attribute_name":"学位授与番号","attribute_value_mlt":[{"subitem_dissertationnumber":"23903甲第1466号"}]},"item_10006_select_8":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_select_item":"博士 (医学)"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"濵野, 真吾"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2015-07-07"}],"displaytype":"detail","filename":"D11Y-1052-hamano.pdf","filesize":[{"value":"181.7 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"D11Y-1052-hamano","url":"https://ncu.repo.nii.ac.jp/record/1089/files/D11Y-1052-hamano.pdf"},"version_id":"1da31192-b447-4497-98ee-824a3875a209"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"thesis","resourceuri":"http://purl.org/coar/resource_type/c_46ec"}]},"item_title":"Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells(トラスツズマブを併用した腫瘍溶解性レオウイルスはヒトHER2陽性胃癌細胞においてTRAILシグナルを介して抗腫瘍効果を増強する)<内容の要旨及び審査結果の要旨>","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells(トラスツズマブを併用した腫瘍溶解性レオウイルスはヒトHER2陽性胃癌細胞においてTRAILシグナルを介して抗腫瘍効果を増強する)<内容の要旨及び審査結果の要旨>"}]},"item_type_id":"10006","owner":"13","path":["302"],"pubdate":{"attribute_name":"公開日","attribute_value":"2015-07-07"},"publish_date":"2015-07-07","publish_status":"0","recid":"1089","relation_version_is_last":true,"title":["Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells(トラスツズマブを併用した腫瘍溶解性レオウイルスはヒトHER2陽性胃癌細胞においてTRAILシグナルを介して抗腫瘍効果を増強する)<内容の要旨及び審査結果の要旨>"],"weko_creator_id":"13","weko_shared_id":-1},"updated":"2023-05-16T07:57:58.071466+00:00"}